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ABSTRACT Sweet potato virus disease (SPVD), caused by synergistic infection of Sweet
potato chlorotic stunt virus (SPCSV) and Sweet potato feathery mottle virus (SPFMV), is re-
sponsible for substantial yield losses all over the world. However, there are currently no
approved treatments for this severe disease. The crucial role played by RNase III of
SPCSV (CSR3) as an RNA silencing suppressor during the viruses’ synergistic interaction
in sweetpotato makes it an ideal drug target for developing antiviral treatment. In this
study, high-throughput screening (HTS) of small molecular libraries targeting CSR3 was
initiated by a virtual screen using Glide docking, allowing the selection of 6,400 com-
pounds out of 136,353. We subsequently developed and carried out kinetic-based HTS
using fluorescence resonance energy transfer technology, which isolated 112 com-
pounds. These compounds were validated with dose-response assays including kinetic-
based HTS and binding affinity assays using surface plasmon resonance and microscale
thermophoresis. Finally, the interference of the selected compounds with viral accumu-
lation was verified in planta. In summary, we identified five compounds belonging to
two structural classes that inhibited CSR3 activity and reduced viral accumulation in
plants. These results provide the foundation for developing antiviral agents targeting
CSR3 to provide new strategies for controlling sweetpotato virus diseases.
IMPORTANCE We report here a high-throughput inhibitor identification method that
targets a severe sweetpotato virus disease caused by coinfection with two viruses
(SPCSV and SPFMV). The disease is responsible for up to 90% yield losses.
Specifically, we targeted the RNase III enzyme encoded by SPCSV, which plays an im-
portant role in suppressing the RNA silencing defense system of sweetpotato plants.
Based on virtual screening, laboratory assays, and confirmation in planta, we identi-
fied five compounds that could be used to develop antiviral drugs to combat the
most severe sweetpotato virus disease.
KEYWORDS viral RNase III, RNA silencing suppressor, inhibitor identification, high-
throughput screening, FRET, synergism, sweetpotato, SPCSV
Sweetpotato is one of the most important staple crops worldwide. More than 30viruses from 9 families have been reported to infect this crop (1). The most devas-
tating and widespread sweetpotato disease, referred to as sweet potato virus disease
(SPVD), is caused by synergism between two viruses, Sweet potato chlorotic stunt virus
(SPCSV) (genus Crinivirus) and Sweet potato feathery mottle virus (SPFMV) (genus
Potyvirus). This disease leads to yield reductions of up to 90% (2, 3). Moreover, SPCSV
can establish synergistic effects with viruses from different genera (e.g., genera
Ipomovirus, Cucumovirus, and Carlavirus), causing aggravated symptoms compared to
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their respective single infections (4). Conventional plant virus control strategies, such
as virus resistance breeding and regeneration of virus-free tissue, have been attempted
to control these synergistic diseases; however, no durable resistant cultivars have been
developed or identified thus far. Furthermore, the combination of virus-free material
with prophylactic measures only slightly limited the spread of SPCSV-mediated syner-
gistic diseases (4–7). Therefore, in this study, we explored a new strategy to control
SPVD, and possibly other SPCSV-mediated synergistic diseases, by identifying inhibi-
tors for the key viral protein of SPCSV that causes synergistic infection.
RNA silencing induced by double-stranded RNA (dsRNA) is a natural antiviral
defense response commonly found in both plants and animals (8–10). However, some
viruses encode one or more proteins that act as RNA silencing suppressors to counter-
act the host’s antiviral defense by interacting with components involved in RNA silenc-
ing (11, 12). The mechanism behind the synergism between SPCSV and other viruses
was shown to be linked to a highly conserved RNase III encoded by SPCSV (CSR3),
which suppresses RNA silencing by cleaving small interfering RNAs (siRNAs) and there-
fore preventing the host antiviral RNA silencing response (13–15). The genome of
SPCSV is composed of two single-stranded plus-sense RNA segments (RNA1 and RNA2)
harboring five and seven open reading frames (ORFs), respectively (16); CSR3 is
encoded by the third ORF from the 39 end of the RNA1 segment. Since CSR3 was
shown to be critical for the establishment of SPCSV viral synergism and disease devel-
opment, CSR3 was seen as a promising target for antiviral drug discovery.
RNase III enzymes are divided into three classes according to the presence of cer-
tain domains (17). Functional and structural studies have shown that CSR3 belongs to
class 1 RNase III enzymes, which contain a single endonuclease domain (endoND) and
a dsRNA-binding domain (dsRBD). Members of this class are found in bacteria, fungi,
and viruses (13, 18) and have been well characterized in Escherichia coli, Aquifex aeoli-
cus, Thermotoga maritima, and Mycobacterium tuberculosis, for which several high-reso-
lution crystal structures are available in the Protein Data Bank (PDB) (19, 20).
Considering the important role of CSR3 (an RNA silencing suppressor) in SPCSV-medi-
ated synergistic interactions and the availability of structural information on class 1
RNase III, the identification of inhibitors could be seen as a promising approach to con-
trol SPVD. However, to date, no compounds have been reported to exhibit any antago-
nism against CSR3 activity. In this study, we performed the first systematic CSR3
inhibitor screening and identification using both in vitro and in vivo methods. These
findings will serve as a promising starting point for the development of effective treat-
ments for virus diseases in sweetpotato plants.
RESULTS
High-throughput screening strategy. The identification of CSR3 inhibitors was
carried out in five phases (Fig. 1). In phase 1, the structure of CSR3 was modeled, and
FIG 1 Workflow of CSR3 inhibitor identification.
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virtual screening using Glide docking was performed with 136,353 compounds that
target the active site of CSR3. In phase 2, compound screening in the laboratory was
first performed with a kinetic-based high-throughput screening (HTS) method that we
developed using fluorescence resonance energy transfer (FRET) technology. Next, the
binding affinity between the compounds and CSR3 was characterized using two com-
plementary assays, microscale thermophoresis (MST) and surface plasmon resonance
(SPR). Phase 3 involved an in vitro screening assay using coinfected (SPCSV and SPFMV)
sweetpotato plants grown in culture medium. The inhibitors’ impact on plant growth
was measured using plant height, and their effects on viral accumulation were moni-
tored by measuring the relative abundances of the transcripts encoding viral coat pro-
teins using reverse transcription-quantitative PCR (RT-qPCR). Phase 4 consisted of a
posterior cluster study of the compounds based on the compound structures. Finally,
phase 5 involved validation assays in planta of plants grown in soil using a plant phe-
notyping platform and the relative expression of viral coat proteins.
Structural modeling and virtual screening. The amino acid sequence analysis
revealed that CSR3 (228 residues) is rather similar in size to RNase III from E. coli (EcR3),
A. aeolicus (AaR3), and T. maritima (TmR3), comprised of 226, 221, and 240 residues,
respectively (Fig. 2A). These three proteins are all prototypical class 1 RNase III enzymes
that have been well studied both structurally and functionally (13, 19, 20). I-TASSER
identified the template’s structure by using the LOMETS server and then selected and
scored the templates with the highest significance in the threading alignments, which
were used to simulate a pool of protein structure decoys. Finally, the top five models
were identified according to pairwise structure similarity using the program SPICKER
(21). In our study, the top identified template structures consisted of the PDB structures
under accession numbers 1O0W, 5B16, 3C4T, 2EB1, 2A11, 2FFI, 3O2R, 2NUG, 1YYK, and
4CE4. We selected the highest-ranked CSR3 model (I-TASSER c score, 0.56; TM score,
0.796 0.09), which is composed of an endoND and a dsRBD connected by a flexible
linker that is similar to those of other class 1 RNase III enzymes (Fig. 2B).
The catalytic activity of RNase III is mediated by two metal ions for which the side
chains of the 4 amino acid residues are negatively charged or can be deprotonated,
allowing the attraction of positively charged metal ions (e.g., Mg21), which further
attract the negatively charged phosphate groups of dsRNA (22). The catalytic site of
CSR3 is composed of the 4 amino acid residues 40E, 44D, 126N, and 129E (Fig. 2A),
whereas 107D in AaR3 corresponds to 126N in CSR3; a superimposed image of the cat-
alytic sites of CSR3 and AaR3 (PDB accession number 2NUG) (1.7 Å) is shown in Fig. 2B.
These results were consistent with those of previous studies demonstrating that these
4 amino acid residues were essential for the catalytic activity of class 1 RNase III
(20, 23). Moreover, previous studies showed that mutations of CSR3 40E and 44D lead
to a loss of function of its endoribonuclease activity on dsRNA and suppression of RNA
silencing (15, 18, 24), confirming their critical function for CSR3 activity.
In this study, the structures of 136,353 small molecules obtained from the High
Throughput Biomedicine Unit of the Institute for Molecular Medicine Finland (HTB-
FIMM) compound libraries were prepared with the LigPreg function of Schrödinger
Maestro using the default setup conditions (25). Residues of the CSR3 activity site were
selected as the center of the Glide-Grid box, and docking was performed using SP and
XP scoring modes using the OPLS3 force field (26). Since the virtual screening was
done using a structural model, we selected a relatively large number of compounds
(6,400) according to their GlideScore rank order for further laboratory screening (their
docking scores are listed in Table S1 in the supplemental material).
Preparation and characterization of the enzyme. His-tagged full-length CSR3
(GenBank accession number ADQ42569.1) was expressed in E. coli and purified with a
nickel-nitrilotriacetic acid (Ni-NTA) affinity column. The size of recombinant CSR3 was
;26 kDa, as shown in Fig. 2C. Under native Western blotting conditions, CSR3 could be
detected as a monomer and a dimer (Fig. 2D); under denatured conditions, CSR3 was
shown to be primarily monomeric in our previous study (24, 27), which is consistent
with the results of SDS-PAGE in Fig. 2C. Although CSR3 could also exist in a tetrameric
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conformation in native Western blots (27), several studies have shown that the homo-
dimer is the biologically active conformation (20, 28, 29). Theoretically, CSR3 could
cleave any size of dsRNA in vitro; thus, its enzymatic activity was evaluated using either
22-bp siRNA or 200-bp dsRNA. Our results demonstrated that both substrates could
be cleaved into smaller fragments by the purified CSR3 (Fig. 2E and F, respectively),
demonstrating its activity.
Kinetic-based HTS. Based on the catalytic activity of CSR3 on 22-bp siRNA, our ki-
netic-based HTS assay was designed using distance-dependent FRET technology.
FIG 2 Homology modeling, purification, and characterization of CSR3. (A) Amino acid sequence alignment of CSR3 and EcR3, TmR3, and AaR3 was
performed using MAFFT. The asterisks, colons, and periods indicate fully conserved, strongly similar, and weakly similar residues, respectively, between
groups. Their active sites are indicated with black arrows. (B) The modeled structure of CSR3, a dimer, was constructed using I-TASSER. The two monomers
of CSR3 are represented in green and gray. Each CSR3 monomer is composed of an endoND and a dsRBD. The superimposed structures of the endoND
active sites of CSR3 and AaR3 (PDB accession number 2NUG) are highlighted in the higher-magnification view. The active site of CSR3 contains 4 amino
acid residues (40E, 44D, 126N, and 129E), which are represented by tubes, and the corresponding amino acid residues of AaR3 are represented by ball-and-
stick models. (C) CSR3 (;26 kDa) purified for HTS was analyzed by SDS-PAGE. (D) Native Western blotting using rabbit polyclonal antibodies against CSR3.
(E and F) CSR3 activity was assessed by agarose gel electrophoresis following incubation of 200-bp (E) and 22-bp (F) dsRNAs at 37°C for 40min either with
CSR3 or without any endoribonuclease enzyme (control [Ctl]). DNA or protein ladders are indicated by L.
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Specifically, one strand of siRNA, as a substrate, was labeled with a fluorescent dye
(6-carboxyfluorescein [FAM]) at the 59 end and a quencher (black hole quencher 1
[BHQ1]) at the 39 end. The initial reaction rate of CSR3 was quantified using the slope
of raw fluorescence under an excitation/emission spectrum at 485/520 nm (Fig. 3A).
According to our previous study (24) detailing CSR3 kinetic-based HTS development
and optimization, this assay was conducted using 100 nM CSR3 enzyme and 375 nM
FIG 3 Inhibitor screening at the molecular level. (A) Schematic diagram of the kinetic-based HTS assay using FRET technology, which represents a 22-bp
labeled siRNA cleaved by CSR3 to generate a fluorescence signal. (B) One-concentration screening using the kinetic-based HTS assay. Fluorescence values
(in relative fluorescence units [RFU]) as a function of the detection cycle number (;17min total) at 37°C show the difference between the positive-control
(uncleaved) and negative-control (cleaved) reactions; values are the means 6 standard deviations (SD) (n= 240) from 20 screening plates. (C) PI distribution
of the 6,622 compounds. (D) Dose-response results using the kinetic-based assay. The Venn diagram shows the 41 candidates selected from three
independent assays using different compound sources: FIMM libraries (FIMM 1 and FIMM 2) or commercial compounds (Comm 1). (E and F) Results of
binding stability of screening compounds using SPR, with a threshold of relative response (RU) value of .10 (E), and their corresponding SPR sensorgrams
(F). (G) Results of the binding affinity assays using MST and SPR highlighting the 30 candidates selected from the kinetic-based assays.
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siRNA substrate over 12 plate read cycles (;17min total) at 37°C. In this study, a total
of 6,622 compounds (including 6,400 selected from Glide docking and 222 empirically
selected compounds for preliminary assay setup) were screened using kinetic-based
HTS at a final concentration of 10mM. All 384-well screening plates contained 32 nega-
tive (with CSR3 [i.e., the substrate was successfully cleaved]) and 32 positive (without
CSR3 [i.e., the substrate remained intact]) control reaction mixtures. To evaluate the
quality of the HTS assay, the Z-factor (Z9) parameter was calculated using the reaction
rates of the positive and negative controls (30). The average Z9 was 0.826 0.04 for the
20 screening plates (0.5 is generally an acceptable threshold for an excellent assay),
indicating that the kinetic-based HTS was technically successful and that the results
were qualitatively and quantitatively adequate. It also showed that the slopes of raw
fluorescence between the negative and positive controls were clearly separated (Fig.
3B). Moreover, the effects of each compound on the reaction rate relative to both con-
trols were used to calculate their percentage of inhibition (PI) (see the equation in
“Data analysis,” below). PI values of the 6,622 compounds can be found in Table S2,
from which a total of 112 compounds with a PI of .30% were selected for further
dose-response testing (see the PI distribution of the 6,622 compounds in Fig. 3C).
Dose-response assay. A dose-response assay with six concentrations (1.25 nM to
50mM) was carried out in three independent experiments, which included two tests
with the 112 selected FIMM compounds (i.e., compounds prepared by the HTB-FIMM)
and one test using the newly ordered commercial compounds (99 of the 112 com-
pounds, i.e., compounds prepared by a second supplier). A dose-response curve was
generated for each compound based on PI values as a function of the concentration.
Along with the half-maximal inhibitory concentration (IC50), the drug sensitivity score
(DSS) was determined for each compound and used for candidate selection (see dose-
response results of the three repeats [FIMM 1, FIMM 2, and Comm 1] in Table S3). DSS
is a parameter that integrates the five characteristics of dose-response curves (IC50,
slope at IC50, minimum activity level, and top and bottom asymptotes) into a single
metric to score the sensitivity of individual compounds, as described previously by B.
Yadav et al. (31), which has been widely used for HTS assays. In this study, based on a
DSS threshold of .4 (ranging from 0 to 22 in our study), 41 compounds were selected
from the three independent assays (Fig. 3D, red circle).
Binding affinity assays using MST and SPR. Binding affinity assays were first car-
ried out with the 99 commercial compounds using the MST method. As a result, 36
compounds of interest were identified based on three criteria: (i) a signal/noise ratio of
.5, (ii) a response amplitude of .4, and (iii) a dissociation constant (Kd) of ,200mM.
The MST binding affinity results of the 36 compounds are listed in Table S4. Based on
the results from the HTS and MST assays, 56 compounds were then screened using
SPR at a concentration of 100mM. Further dose-response testing over 12 concentra-
tions (3mM to 200mM) was performed with 44 compounds that showed a relative
response unit (RU) value of .10 (Fig. 3E and F). Based on the steady-state affinity (KD)
and the kinetics in the dose-response assay, 36 compounds of interest were identified
(binding affinity results of SPR can be found in Table S5). Altogether, at the molecular
level, based on the results of the kinetic-based HTS assay and the union set of MST and
SPR, 30 compounds were considered potential CSR3 inhibitors (Fig. 3G).
Inhibitor screening in plants grown in culture medium. Since tests in culture me-
dium consume smaller amounts of compounds and can be carried out under relatively
controlled conditions, sweetpotato plants coinfected with SPCSV and SPFMV were
grown in medium supplemented with one of the 30 inhibitor candidates at a concen-
tration of 50mM. Their effects on plant growth were monitored by imaging the plants
once a week. Two of the 30 compounds were excluded due to obvious stress symp-
toms such as deformation, wilting, bleaching, dried leaf margins, or severe growth
defects, possibly because of their toxicity in plants. In addition, virus accumulation was
quantified by measuring the relative abundance of the transcripts encoding viral coat
proteins using RT-qPCR (32). The effect of individual compounds on virus accumulation
was estimated by comparing treated and control plants.
Wang et al. Journal of Virology












































With a fold change of viral accumulation of ,0.6, 7 and 11 compounds had nega-
tive effects on SPFMV and SPCSV accumulation in plants, respectively. Five common
compounds showing negative effects on both SPFMV and SPCSV accumulation were
selected (Table S6). Specifically, SPCSV accumulation was reduced approximately 8-
fold by two compounds (FIMM022230 and FIMM005536), 4-fold by two compounds
(FIMM051696 and FIMM000096), and 2-fold by the compound FIMM031755. SPFMV
accumulation was reduced almost 4-fold by three compounds (FIMM022230,
FIMM005536, and FIMM051696) and 2-fold by two compounds (FIMM000096 and
FIMM031755) (Fig. 4A). Overall, these five compounds reduced both SPCSV and SPFMV
accumulation without any phytotoxicity effects on sweetpotato plants (see experimen-
tal plant pictures in Fig. 4B and their effects on plant growth indicated by plant height
over time in Fig. 4C and D).
Structural clustering of the compounds. The five inhibitors were clustered hier-
archically into two classes. FIMM000096 was placed into class 1, whereas the other
four compounds (FIMM005536, FIMM031755, FIMM051696, and FIMM022230) were
placed into class 2 and had highly similar structures (Fig. 5A; information on their mo-
lecular formulas, suppliers, molecular weights, and simplified molecular-input line-
entry system (SMILES), etc., can be found in Table S7). Altogether, the kinetic-based
FIG 4 Results of inhibitor screening in vivo. (A) Reduction of SPCSV and SPFMV accumulation induced by the top five compounds using RT-qPCR,
represented as the log2 fold change in the accumulation of the coat protein-encoding viral RNAs. Values are the means 6 standard errors (SE) (n= 3
plants). (B) Representative pictures of plants grown in culture medium supplemented with the five compounds or with 0.1% DMSO for 28 days. (C) Effects
of the five compounds on plant height were measured every week. Data are shown as the means 6 SE (n= 3). (D) Growth rate calculated with plant
height between days 7 and 28 as a function of days. There is no significant difference between treated plants and DMSO plants (control) according to a
Dunnett test (confidence level of 0.95).
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HTS revealed that the compounds had similar DSS and IC50 values ranging from 12.4 to
15.9 and 1.27 to 2.95mM, respectively. The reduction of virus accumulation in plants in
the presence of the compounds resulted in a log2 fold change of 20.77 to 23.56 rela-
tive to the controls; the Kd of MST or the KD of SPR values from the binding affinity
experiments ranged from 0.69mM to 3.44mM for these compounds (Fig. 5A).
Furthermore, as illustrated by agarose gel electrophoresis, labeled siRNAs remained
intact in the reaction mixtures containing siRNA, CSR3, and any of the five compounds,
which is similar to the positive control (containing siRNA alone), while siRNAs were
fragmented and no clear bands could be observed in the negative control (siRNA incu-
bated with only CSR3) (Fig. 5B). Overall, these results showed that all five compounds
can prevent CSR3-mediated siRNA cleaving, validating their ability to inhibit the endor-
ibonuclease activity of CSR3 in biochemistry.
Inhibitor validation in plants grown in soil. Four of the five inhibitors
(FIMM000096, FIMM031755, FIMM022230, and FIMM005536) were available in sufficient
amounts to further confirm their effects on coinfected sweetpotato plants grown in soil
using a plant phenotyping platform. Compounds were administered by regular foliar
FIG 5 Hierarchical clustering of the selected compounds based on structure. (A) The five compounds were clustered into two classes using the Tanimoto
coefficient, WardLinkage, and a threshold of 0.5 (ChemBioServer). The structure of the compounds and their IC50 and DSS values from kinetic-based HTS,
their Kd or KD values from affinity binding assays (by either MST or SPR), and their effects on viral accumulation (log2 fold change relative to controls) in
plants are summarized. (B) Electrophoresis in a 2.5% agarose gel of labeled siRNA incubated for 30min at 37°C with CSR3 and/or the five compounds. The
composition of the reaction mixture is the same as that for HTS screening.
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spray over 1 month. At the end of these treatments, we observed reductions of SPFMV
accumulation (;1.5- to 2-fold on average) and SPCSV accumulation (;0.8- to 5-fold on
average) in all four treatments compared to the untreated plants, although these reduc-
tions of viral titers, represented by log2 fold changes in coat protein expression, were stat-
istically significant for SPFMV but not for SPCSV due to higher variability. Specifically, the
log2 fold changes are 21.06, 21.33, 20.73, and 21.36 for SPFMV and 21.41, 21.30,
20.58, and21.67 for SPCSV (Fig. 6A and B). This phenomenon is consistent with our pre-
vious conclusion that the more severe disease in coinfected plants is linked to an increase
of the SPFMV titer (instead of the SPCSV titer), which is induced by CSR3 of SPCSV (33). At
the morphological level, none of the treated plants showed signs of plant stress, as illus-
trated by the imaging results of the red, green, and blue (RGB) color mode in Fig. 6C.
At the physiological level, the quantum yield of photosystem II (UPSII) was used to
monitor their effect on photosynthetic performance. Our previous data showed that
UPSII, which indicates the proportion of light used by chlorophyll associated with PSII,
is an efficient estimator of viral effects on sweetpotato plants (33). In this study, all four
compounds caused a significant increase in UPSII values compared with the control
values, reflecting an improvement of the photosynthetic performance in treated plants
compared to untreated ones (Fig. 6D). Taken together, these results demonstrated that
the four compounds had a positive effect on the photosynthetic performance of coin-
fected sweetpotato plants. Finally, a summary of all assay steps is shown in Table 1.
FIG 6 Inhibitor validation in planta using coinfected sweetpotato plants grown in soil. (A and B) The effects of four of the five compounds on viral
accumulation were assessed in the coinfected sweetpotato plant by measuring the log2 fold change in coat protein expression of SPFMV (A) and SPCSV (B)
compared to the water-treated plant (Ctl) using RT-qPCR. Data represent the means6 95% confidence intervals (n= 10 plants). *, P, 0.05; **, P, 0.01; ***,
P, 0.001 (based on Dunnett’s test for comparing several treatments with a control). (C) Top-view images of coinfected sweetpotato plants treated with
one of the four compounds or water (Ctl) for 1 month. Photographs were obtained on day 41 by RGB imaging or ChlF imaging (UPSII). False-color images
displaying UPSII values pixel by pixel were generated using a heat map color scale from dark blue to red, ranging from 0.3 to 0.8. (D) Overall quantum
yield of PSII (UPSII) values of plants treated twice a week with one of the four compounds or water (Ctl_1 and Ctl_2) for 1 month. Experiments were
carried out in two batches, each of which included a control condition and five plants per treatment. Values for UPSII were measured every day from day
37 to day 41 after plantlets were transferred to soil; these are shown in the box plots. *, P, 0.05; **, P, 0.01; ***, P, 0.001 (based on Dunnett’s test for
comparing several treatments with a control).
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Considering all screening steps, four compounds (hit rate of 0.0029%) were identified
as inhibitors of CSR3.
DISCUSSION
Currently, antiviral strategies in plants are based on either breeding virus-resist-
ant cultivars or targeting viruses to prevent viral replication and spread (6, 34, 35).
Typically, most virus control strategies are applied to preinfected plants, emphasiz-
ing the need to develop alternative antiviral strategies that are effective in postin-
fected plants. Indeed, searching for antiviral compounds that are capable of inhibi-
ting essential steps in the virus life cycle may constitute a new means for
counteracting disease development. Chemotherapy strategies widely used to treat
animal viruses are rarely reported in plant virus studies (36). Nevertheless, RNA
silencing suppressors, encoded by many viruses, have been shown to be essential
for the collapse of antiviral defense (37–39). Moreover, the possibility of interfering
with their activity was seen as a promising strategy to control viral diseases. RNA
silencing suppressors of Tombusvirus P19 (binding to siRNAs and therefore prevent-
ing their incorporation into RNA-induced silencing complex) have been targeted in
inhibitors studies using an electrophoretic mobility shift assay, SPR, and/or fluores-
cence detection on Ni21-NTA plates. These studies have led to the identification of
chemical inhibitors interfering with its binding activity (40–42).
Great interest in RNA interference (RNAi) research has been shown over the last 2
decades, and RNAi-related technologies remain crucial for developing crop protections
against viruses (43). The engineering of virus-resistant crops has mainly focused on the
integration of dsRNA coding for key viral proteins to trigger an RNAi defense response
against targeted viruses. Moreover, recent studies showed that the exogenous applica-
tion of RNA molecules (dsRNAs, siRNAs, hairpinRNAs [hpRNas], and microRNAs
[miRNAs]) in plants through either coinoculation, agroinfiltration, or spraying can be
sufficient to induce RNAi-mediated defense and eliminate virus accumulation up to
20 days posttreatment (44–46). Exogenous application of RNA molecules has been
studied in many different viruses, such as Pepper mild mottle virus (PMMoV) (47),
Tobacco mosaic virus (TMV) (48), and Bean common mosaic virus (BCMV) (45).
The present study focused on the identification of inhibitors of the RNA silencing
suppressor CSR3 expressed by SPCSV, which, together with SPFMV, plays a central role
in the development of the devastating viral disease in sweetpotatoes. CSR3 is an
endoribonuclease belonging to the class 1 RNase III family. Until now, other endoribo-
nucleases that have been targeted in inhibitor/activator identification include RNase H
of HIV and a broad-spectrum antiviral RNase L of mammalian cells (49, 50). Although
some RNase H inhibitors have been found, RNase H enzymes are functionally very dif-
ferent from class 1 RNase IIIs. For example, RNase H enzymes hydrolyze the RNA
strands of DNA/RNA duplexes during reverse transcription (50). As expected, none of
the RNase H inhibitors bind to CSR3 in silico (data not shown); thus, we employed a
combination of in silico screening, kinetic- and affinity-based laboratory screening, and
TABLE 1 Summary of screening and validation of compounds
Step No. of compounds tested Screening concn No. of compounds identified Hit rate (%)
In silico 136,353 6,400 4.69
FRET 6,622 10mM 112 1.69
FRET 99–112 1.25 nM–50mM 41 37.6
MST 99 0.2mM–400mM 36 36.4
SPR 56 100mM 42 75.0
SPR 42 3mM–200mM 36 85.7
In vitro screening (grown in medium) 30 50mM 5 16.7
In vitro validation (grown in soil) 4 10mM 4 100
Total 136,353 4 0.0029
Wang et al. Journal of Virology












































in vivo confirmation assays to identify inhibitors of the viral CSR3. As a result, five novel
inhibitors of viral RNase III were identified, all of which showed the ability to negatively
impact viral accumulation in sweetpotato.
Computer-aided molecular docking has played an important role in the early stages
of drug discovery, allowing systematic calculation of ligand-protein interactions. Glide
docking, used in our study, is a complete and hybrid method for searching for poten-
tial docking poses with high accuracy (51). Targeting the highly conserved active site
of CSR3, as done in this study, could reduce the likelihood that resistance will develop
within the virus population (52), which is important in the development of sustainable
antiviral strategies. However, because a modeled CSR3 structure was used instead of a
crystal structure, we screened a relatively large number (6,622) of small molecules with
the kinetic-based assay.
Laboratory HTS in this study was performed using FRET technology. FRET-based
methods have advantages, such as sensitivity and efficiency, but also disadvantages, as
they are likely to produce false-positive and false-negative results (53, 54). In our study,
false-negative findings were possible if compounds quenched the reporter fluoro-
phore. False-positive results were possible under two conditions: (i) if compounds
directly interacted with the substrate instead of CSR3 to prevent cleavage of the la-
beled siRNA and (ii) if compounds exhibited intrinsic fluorescence with absorption and
emission spectra similar to those of the fluorophore reporter. To exclude false-positive
results, two complementary methods, MST and SPR, were applied to directly measure
the binding affinity between CSR3 and the studied compounds. MST is a fluorescence-
based method used to record the motion of molecules in microscopic temperature
gradients and detect changes in hydration shell, charge, or size (55); therefore, it is sus-
ceptible to disruption by intrinsically fluorescent compounds. However, SPR is used to
monitor small changes in the optical reflective index at the sensor surface induced by
an affinity interaction between the protein and the compound (56). If a compound
does not properly dissociate from the sensor, it will affect the assay of the next analyte.
Moreover, it is possible that certain small molecules will bind to the sensor surface (57,
58), resulting in a relatively wide range of KD values. For example, FIMM022230 had a
high KD in the millimolar range for steady-state affinity (Fig. 5A).
To exclude inhibitors that interfere with endogenous RNase III and impact plant
growth, a combination of molecular methods and imaging-based techniques was per-
formed directly on sweetpotato plants grown in medium and/or soil. Most of the com-
pounds (28 of 30) were not toxic to plants, and the accumulation of both SPCSV and
SPFMV in plants grown in medium was reduced by five inhibitors. Structurally, these
five compounds were clustered into two classes. These compounds were then used to
further characterize existing molecules to identify optimal candidates by studying
structure-activity relationships (59). Among the five inhibitors, the class 1 compound
FIMM000096 has been approved as a powerful emetic and has also been used in the
treatment of parkinsonism but with adverse effects (https://www.drugbank.ca/drugs/
DB00714). To the best of our knowledge, the other four compounds, which belong to
class 2, have not been reported either in the DrugBank database or for the treatment
of viral diseases. However, they have been included in inhibitor screens for human
enzymes or bacterial proteins according to their PubChem identifiers: compound identi-
fier (CID) 2948389 (FIMM022230), CID 7114450 (FIMM031755), CID 2857906
(FIMM005536), and CID 4240943 (FIMM051696). They all were inactive in the studies
except for FIMM031755, which affected the activity of chain B of the human cytokine/re-
ceptor binary complex (https://pubchem.ncbi.nlm.nih.gov/compound/7114450#section=
Biological-Test-Results). Moreover, FIMM031755 has also been screened in our latest arti-
cle about the development of a FRET-based screening method (24). The class 2 com-
pounds, which share the same core structure but have different R groups, had different
binding affinities, providing evidence for further analyses of structure-activity relation-
ships. Although these compounds had beneficial effects on SPCSV- and SPFMV-infected
sweetpotato plants grown in medium and soil, many other bioactivity, toxicity, and
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in vivo tests are still needed to develop antiviral agents that can be used in the field. The
results reported here will aid in developing new strategies to combat the most severe
and widespread sweetpotato viral disease, as four of the five candidates were also con-
firmed to positively impact plant performance by using a chlorophyll fluorescence (ChlF)
imaging-based platform. Moreover, another similar RNase III has been found in Pike-perch
iridovirus (PPIV) in fish (15); therefore, it is possible that more RNase III-like RNA silencing
suppressors could be identified. Hence, our HTS method could be easily adapted for in-
hibitor identification for other viruses.
Until now, due to the difficulty in achieving broad viral resistance to different virus
strains or genera, research studies have been focusing on approaches that could sus-
tain protection against specific viruses, mainly using transgenic expression or exoge-
nous application of RNA molecules to trigger RNAi-mediated plant defense mecha-
nisms. Compared to those approaches that artificially induce RNAi defense to
eliminate virus accumulation at the RNA level, the compounds (viricides) identified in
this study directly target and inactivate a viral protein playing a key role in viral coun-
terdefense. As all methods have their own merits and demerits, the exogenous applica-
tion of RNA molecules is facing stability and suitability problems, while virus-resistant
breeding, achieved by the generation of genetically modified organisms (GMOs), has
raised considerable public concerns. Like pesticides, the application of viricides can be
considered an attractive method considering its potential in those aspects. Besides,
those compounds were selected for targeting a specific, highly conserved activity site,
which could limit resistance-breaking events and allow further development for lower
dosages, therefore reducing off-target effects. However, compound methods (viricides
or pesticides) are associated with health risks for farmers, consumers, and the environ-
ment, which require extensive study before field application worldwide. Last but not
least, for both exogenous methods (RNA molecules and compounds), costs for devel-
opment and application will be a key factor toward practical application in the field.
MATERIALS ANDMETHODS
Protein expression, purification, and activity assay. CSR3 (GenBank accession number ADQ42569
.1) was fused to 6His at its C terminus in the pET11d vector and expressed in E. coli BL21 (15, 18).
Bacterial cells were cultured under selection with ampicillin (100mg/ml) and chloramphenicol (25mg/
ml) at 37°C for 2 h (optical density [OD] of 0.5 to 0.6). CSR3 expression was induced with 0.1mM isopro-
pyl-b-D-1-thiogalactopyranoside (IPTG), and cells were harvested after 4 h at 37°C. Bacterial cells were
first purified with Ni-NTA agarose (Qiagen, Venlo, Netherlands) and then lysed with lysozyme at a final
concentration of 1mg/ml (Sigma-Aldrich, St. Louis, MO, USA). The lysis, wash, and elution steps were
performed using a His buffer kit (GE Healthcare, Chicago, IL, USA). The purified protein was stored in a
buffer (20mM Tris-HCl [pH 8], 50mM NaCl, 10mM MgCl2, 5% glycerol) using a buffer exchange column
(PD MidiTrap G-25; GE Healthcare). Proteins were visualized on SDS-PAGE gels and quantified with a
NanoDrop apparatus (Thermo Fisher Scientific, Waltham, MA, USA). The activity of CSR3 was tested using
a 200-bp dsRNA substrate in a 20-ml reaction buffer (20mM Tris-HCl [pH 8], 50mM NaCl, 10mM MgCl2);
after incubation for 40min at 37°C, the sample was analyzed on a 1% agarose gel.
Homology modeling and virtual screening. EcR3, TmR3, and AaR3 from E. coli, T. maritima, and A.
aeolicus, respectively, were used for sequence alignment with MAFFT (60). The structural model of CSR3
was generated with I-TASSER (61). I-TASSER was used to identify the template’s structure using the
LOMETS server and then to select and score the templates with the highest significance in the threading
alignments, which were used to simulate a pool of protein structure decoys. Finally, the top five models
were identified according to pairwise structure similarity using the program SPICKER (21). In our study,
the top identified template structures consisted of the PDB structures under accession numbers 1O0W,
5B16, 3C4T, 2EB1, 2A11, 2FFI, 3O2R, 2NUG, 1YYK, and 4CE4. The highest-ranked model was selected for
Glide docking analysis, which was processed with the Protein Preparation Wizard of Schrödinger (release
2016-4; Schrödinger LLC, NY, USA). The structures of compounds were prepared with the LigPreg func-
tion of Schrödinger using the default setup conditions. Four residues at the active site of CSR3 were
selected as the center of the Glide-Grid box, and docking was performed using SP and XP scoring modes
using the OPLS3 force field (26, 51). The top 6,622 compounds were selected based on the GlideScore
rankings.
Laboratory screening using FRET. The HTS assay was designed based on FRET using a 22-bp siRNA
(forward sequence, CGUAGUGGAAGUGGGAGAGGTC; reverse sequence, CCUCUCCCACUUCCACUACGTG)
with a 2-nucleotide (nt) 39 overhang labeled with the fluorescent dye 6-carboxyfluorescein (FAM) and a
black hole quencher (BHQ1) on the sense strand (Metabion, Munich, Germany). Screening was initially
carried out at one concentration (10mM) in a 20-ml reaction buffer. A dose-response assay was subse-
quently carried out at six concentrations (1.25 nM, 10 nM, 100 nM, 1mM, 10mM, and 50mM) to determine
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the IC50 and DSS values. All reaction mixtures contained 50 nM CSR3 and 375 nM labeled siRNA in 384-
well black flat-bottom microplates (Corning, NY, USA) and were prepared using a BioTek MultiFlo FX dis-
penser with single-channel random access dispenser cassettes (BioTek, Winooski, VT, USA). The plates
were read with a PHERAstar FS reader (BMG Labtech, Ortenberg, Germany).
Binding affinity assay using MST. Proteins were labeled using Red-Tris-NTA dye (NanoTemper,
Munich, Germany) and resuspended in 50ml of phosphate-buffered saline (PBS) buffer (137mM NaCl,
2.7mM KCl, 10mM Na2HPO4, 2mM KH2PO4 [pH 7.4]) with 0.05% Tween 20 to obtain a 5mM dye solution.
The labeled-protein solution containing 500 nM proteins and 40nM dye was prepared in PBS buffer with
2% dimethyl sulfoxide (DMSO) for the assay. The 12 concentrations for each compound were obtained
by 2-fold serial dilutions (0.2mM to 400mM). A peptide control was included to discriminate binding-
specific fluorescence quenching from the loss of fluorescence due to protein precipitation. Two inde-
pendent experiments were carried out in premium coated capillaries (NanoTemper, Munich, Germany)
using a Monolith NT.Automated instrument (NanoTemper) with the power set at high (80%), the light-
emitting diode (LED) power (pico red) set at 5%, and the on-time set at 20 s. The dissociation constant
(Kd) was determined using the MO.Affinity Analysis program (NanoTemper).
Binding affinity assay using SPR. CSR3 was purified as described above and stored in PBS buffer.
SPR was performed on a BiacoreT100 instrument (GE Healthcare) using a sensor S CM5 chip (GE
Healthcare). CSR3 (10 ng/ml) was immobilized using the standard amine-coupling method according to
the manufacturer’s instructions with immobilization buffer (10mM sodium acetate [pH 4]); the final
response unit (RU) value was 11,459. Compounds at a single concentration (100mM) or consisting of 2-
fold serial dilutions (3mM to 200mM) were flowed over the sensor surface using PBS buffer with 0.01 M
HEPES, 0.05% surfactant P20, and 2% DMSO. Compounds were tested from lower to higher concentra-
tions at 25°C, and injection and dissociation were performed at a flow rate of 30ml/min for 60 s and 300
s, respectively. To eliminate bulk interference by DMSO, a solvent correction consisting of DMSO at con-
centrations ranging from 1.5% to 2.8% was carried out for every 30 samples. Steady-state affinity (KD)
values were determined using BiacoreT100 Evaluation software, v.2.04 (GE Healthcare).
Plant material, growth conditions, and phenotyping. Sweetpotato plants cultivar 'Huachano'
(accession CIP420065) were side-graft inoculated with both SPFMV (East African strain isolate Nam1) and
SPCSV-Ug (East African serotype 2) as described previously (62). Plantlets were propagated by taking sin-
gle-node stems grown in a plant culture medium (33). Next, plantlets with newly formed roots were
transferred to glass tubes (18 by 150mm) containing 10ml of medium supplemented with either 50mM
compound (diluted in DMSO; final DMSO concentration, 0.1%) or only 0.1% DMSO as a control. For plant
experiments in soil, plantlets were transferred to pots (6 by 6 by 10 cm) filled with a mixture of sand, hu-
mus, and washed soil. After 1week, plants were treated by foliar spraying using either individual com-
pounds at a single concentration (10mM) (treatment) or water (control/mock) twice a week for 1month.
All plants were grown at 22°C with 60% humidity and a 16-h light/8-h dark photoperiod for 28 days in
culture medium and for 41 days in soil. The Finnish National Plant Phenotyping Infrastructure (NaPPI)
was used to monitor plant viral disease symptoms as described in our previous study (33). Four com-
pounds were tested with the phenotyping platform in two independent batches, each of which
included five biological replicates.
Virus accumulation assay with RT-qPCR. Leaf samples were collected from plants grown in culture
medium or soil for 28 or 41 days, respectively, and frozen in liquid nitrogen. Total RNA was extracted
using the Spectrum plant total RNA kit (Sigma-Aldrich). First-strand cDNA was synthesized using the
Transcriptor first-strand cDNA synthesis kit (Roche, Basel, Switzerland). Gene expression was measured
in a final volume of 10ml (containing 2ml 10-fold-diluted cDNA, 5ml SYBR green I master mix [Roche],
and 2.5mM primers) using the LightCycler 480 instrument II (Roche). All RT-qPCR experiments were con-
ducted in triplicate on three and five biological replicates from plants grown in culture medium and soil,
respectively. The primer list can be found in our previous study (33).
Data analysis. For HTS, the activity of CSR3 was calculated by measuring the change in fluorescence
as a function of the reaction time using MARS Data Analysis software (BMG Labtech). To evaluate the
CSR3 inhibition efficiency of individual compounds, the PI of each compound was calculated using the
slope values for the sample, positive control, and negative control according to the following equation:
PI = 100  [1 2 (sample 2 positive)/(negative 2 positive)]%. IC50 and DSS values were calculated using
concentration-specific PI values according to a previous study (31). Relative gene expression was calcu-
lated using the classical 22DDCT method (63).
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
SUPPLEMENTAL FILE 1, XLSX file, 2.1 MB.
SUPPLEMENTAL FILE 2, PDF file, 0.1 MB.
ACKNOWLEDGMENTS
This work was supported by the China Scholarship Council (State Scholarship Fund
grant number 201406040060) and the Bill & Melinda Gates Foundation, Seattle, WA
(NextGen Phytosanitation).
We thank Laura Turunen and Swapnil Potdar from the Institute for Molecular
Medicine Finland (FIMM) for their technical help, Kristiina Himanen and Mirko Pavicic
Inhibitor Identification for a Viral RNase III Journal of Virology












































from the Plant Phenomics Research Group for support with the NaPPI platform, and
Katrin Artola from the Plant Pathology Research Group for assistance and advice. The
DDCB core facility (FIMM HTB unit) is supported by the University of Helsinki and
Biocenter Finland.
L.W. contributed to designing the study, performing the experiments, interpreting
the data, and writing the draft of the paper. S.P. and J.S. contributed to performing the
experiments and reviewing the paper. K.L. contributed to performing the experiments.
A.P., T.L., and J.P.T.V. contributed to reviewing the paper.
We declare that the results of this research are included in patent application FI
20205392, which could relate to financial interests.
REFERENCES
1. Clark CA, Davis JA, Abad JA, Cuellar WJ, Fuentes S, Kreuze JF, Gibson RW,
Mukasa SB, Tugume AK, Tairo FD, Valkonen JP. 2012. Sweetpotato viruses:
15 years of progress on understanding and managing complex diseases.
Plant Dis 96:168–185. https://doi.org/10.1094/PDIS-07-11-0550.
2. Gibson RW, Kreuze JF. 2015. Degeneration in sweetpotato due to viruses,
virus-cleaned planting material and reversion: a review. Plant Pathol
64:1–15. https://doi.org/10.1111/ppa.12273.
3. Njeru RW, Mburu MWK, Cheramgoi E, Gibson RW, Kiburi ZM, Obudho E,
Yobera D. 2004. Studies on the physiological effects of viruses on sweet
potato yield in Kenya. Ann Appl Biol 145:71–76. https://doi.org/10.1111/j
.1744-7348.2004.tb00360.x.
4. Untiveros M, Fuentes S, Salazar LF. 2007. Synergistic interaction of Sweet
potato chlorotic stunt virus (Crinivirus) with carla-, cucumo-, ipomo-, and
potyviruses infecting sweet potato. Plant Dis 91:669–676. https://doi.org/
10.1094/PDIS-91-6-0669.
5. Ngailo S, Shimelis H, Sibiya J, Mtunda K, Mashilo J. 2019. Genotype-by-
environment interaction of newly-developed sweet potato genotypes for
storage root yield, yield-related traits and resistance to sweet potato virus
disease. Heliyon 5:e01448. https://doi.org/10.1016/j.heliyon.2019.e01448.
6. Okada Y, Kobayashi A, Tabuchi H, Kuranouchi T. 2017. Review of major
sweetpotato pests in Japan, with information on resistance breeding pro-
grams. Breed Sci 67:73–82. https://doi.org/10.1270/jsbbs.16145.
7. Wang Q, Valkonen JP. 2009. Cryotherapy of shoot tips: novel pathogen
eradication method. Trends Plant Sci 14:119–122. https://doi.org/10
.1016/j.tplants.2008.11.010.
8. Qu F. 2010. Plant viruses versus RNAi: simple pathogens reveal complex
insights on plant antimicrobial defense. Wiley Interdiscip Rev RNA
1:22–33. https://doi.org/10.1002/wrna.7.
9. Agrawal N, Dasaradhi P, Mohmmed A, Malhotra P, Bhatnagar RK,
Mukherjee SK. 2003. RNA interference: biology, mechanism, and applica-
tions. Microbiol Mol Biol Rev 67:657–685. https://doi.org/10.1128/mmbr
.67.4.657-685.2003.
10. Li F, Wang A. 2019. RNA-targeted antiviral immunity: more than just RNA
silencing. Trends Microbiol 27:792–805. https://doi.org/10.1016/j.tim
.2019.05.007.
11. Burgyan J, Havelda Z. 2011. Viral suppressors of RNA silencing. Trends
Plant Sci 16:265–272. https://doi.org/10.1016/j.tplants.2011.02.010.
12. Niehl A, Wyrsch I, Boller T, Heinlein M. 2016. Double-stranded RNAs
induce a pattern-triggered immune signaling pathway in plants. New
Phytol 211:1008–1019. https://doi.org/10.1111/nph.13944.
13. Cuellar WJ, Kreuze JF, Rajamaki ML, Cruzado KR, Untiveros M, Valkonen
JP. 2009. Elimination of antiviral defense by viral RNase III. Proc Natl Acad
Sci U S A 106:10354–10358. https://doi.org/10.1073/pnas.0806042106.
14. Tugume AK, Amayo R, Weinheimer I, Mukasa SB, Rubaihayo PR, Valkonen
JP. 2013. Genetic variability and evolutionary implications of RNA silenc-
ing suppressor genes in RNA1 of sweet potato chlorotic stunt virus iso-
lates infecting sweetpotato and related wild species. PLoS One 8:e81479.
https://doi.org/10.1371/journal.pone.0081479.
15. Weinheimer I, Jiu Y, Rajamaki ML, Matilainen O, Kallijarvi J, Cuellar WJ, Lu R,
Saarma M, Holmberg CI, Jantti J, Valkonen JP. 2015. Suppression of RNAi by
dsRNA-degrading RNaseIII enzymes of viruses in animals and plants. PLoS
Pathog 11:e1004711. https://doi.org/10.1371/journal.ppat.1004711.
16. Kreuze JF, Savenkov EI, Valkonen JPT. 2002. Complete genome sequence
and analyses of the subgenomic RNAs of Sweet potato chlorotic stunt vi-
rus reveal several new features for the genus Crinivirus. J Virol
76:9260–9270. https://doi.org/10.1128/jvi.76.18.9260-9270.2002.
17. Du Z, Lee JK, Tjhen R, Stroud RM, James TL. 2008. Structural and biochem-
ical insights into the dicing mechanism of mouse Dicer: a conserved ly-
sine is critical for dsRNA cleavage. Proc Natl Acad Sci U S A
105:2391–2396. https://doi.org/10.1073/pnas.0711506105.
18. Kreuze JF, Savenkov EI, Cuellar W, Li X, Valkonen JP. 2005. Viral class 1
RNase III involved in suppression of RNA silencing. J Virol 79:7227–7238.
https://doi.org/10.1128/JVI.79.11.7227-7238.2005.
19. Kharrat A, Macias M, Gibson T, Nilges M, Pastore A. 1995. Structure of the
dsRNA binding domain of E. coli RNase III. EMBO J 14:3572–3584. https://
doi.org/10.1002/j.1460-2075.1995.tb07363.x.
20. Court DL, Gan J, Liang YH, Shaw GX, Tropea JE, Costantino N, Waugh DS,
Ji X. 2013. RNase III: genetics and function; structure and mechanism.
Annu Rev Genet 47:405–431. https://doi.org/10.1146/annurev-genet
-110711-155618.
21. Roy A, Kucukural A, Zhang Y. 2010. I-TASSER: a unified platform for auto-
mated protein structure and function prediction. Nat Protoc 5:725–738.
https://doi.org/10.1038/nprot.2010.5.
22. Nicholson AW. 2014. Ribonuclease III mechanisms of double-stranded
RNA cleavage. Wiley Interdiscip Rev RNA 5:31–48. https://doi.org/10
.1002/wrna.1195.
23. Akey DL, Berger JM. 2005. Structure of the nuclease domain of ribonucle-
ase III from M. tuberculosis at 2.1 Å. Protein Sci 14:2744–2750. https://doi
.org/10.1110/ps.051665905.
24. Wang L, Saarela J, Poque S, Valkonen JPT. 2020. Development of FRET-
based high-throughput screening for viral RNase III inhibitors. Mol Plant
Pathol 21:961–974. https://doi.org/10.1111/mpp.12942.
25. Good AC, Oprea TI. 2008. Optimization of CAMD techniques 3. Virtual
screening enrichment studies: a help or hindrance in tool selection? J
Comput Aided Mol Des 22:169–178. https://doi.org/10.1007/s10822-007
-9167-2.
26. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA,
Sanschagrin PC, Mainz DT. 2006. Extra precision glide: docking and scoring
incorporating a model of hydrophobic enclosure for protein-ligand com-
plexes. J Med Chem 49:6177–6196. https://doi.org/10.1021/jm051256o.
27. Weinheimer I, Boonrod K, Moser M, Wassenegger M, Krczal G, Butcher SJ,
Valkonen JP. 2014. Binding and processing of small dsRNA molecules by
the class 1 RNase III protein encoded by sweet potato chlorotic stunt vi-
rus. J Gen Virol 95:486–495. https://doi.org/10.1099/vir.0.058693-0.
28. Liang YH, Lavoie M, Comeau MA, Abou Elela S, Ji X. 2014. Structure of a
eukaryotic RNase III postcleavage complex reveals a double-ruler mecha-
nism for substrate selection. Mol Cell 54:431–444. https://doi.org/10
.1016/j.molcel.2014.03.006.
29. Gan J, Tropea JE, Austin BP, Court DL, Waugh DS, Ji X. 2006. Structural
insight into the mechanism of double-stranded RNA processing by ribo-
nuclease III. Cell 124:355–366. https://doi.org/10.1016/j.cell.2005.11.034.
30. Zhang JH, Chung TD, Oldenburg KR. 1999. A simple statistical parameter
for use in evaluation and validation of high throughput screening assays.
J Biomol Screen 4:67–73. https://doi.org/10.1177/108705719900400206.
31. Yadav B, Pemovska T, Szwajda A, Kulesskiy E, Kontro M, Karjalainen R,
Majumder MM, Malani D, Murumagi A, Knowles J, Porkka K, Heckman C,
Kallioniemi O, Wennerberg K, Aittokallio T. 2014. Quantitative scoring of
differential drug sensitivity for individually optimized anticancer thera-
pies. Sci Rep 4:5193. https://doi.org/10.1038/srep05193.
32. Kokkinos CD, Clark C. 2006. Real-time PCR assays for detection and quan-
tification of sweetpotato viruses. Plant Dis 90:783–788. https://doi.org/10
.1094/PD-90-0783.
Wang et al. Journal of Virology












































33. Wang L, Poque S, Valkonen JPT. 2019. Phenotyping viral infection in
sweetpotato using a high-throughput chlorophyll fluorescence and ther-
mal imaging platform. Plant Methods 15:116. https://doi.org/10.1186/
s13007-019-0501-1.
34. Jones RA. 2006. Control of plant virus diseases. Adv Virus Res 67:205–244.
https://doi.org/10.1016/S0065-3527(06)67006-1.
35. Yu Y, Wang X, Sun H, Liang Q, Wang W, Zhang C, Bian X, Cao Q, Li Q, Xie
Y, Ma D, Li Z, Sun J. 2020. Improving CRISPR-Cas-mediated RNA targeting
and gene editing using SPLCV replicon-based expression vectors in Nic-
otiana benthamiana. Plant Biotechnol J 18:1993–1995. https://doi.org/10
.1111/pbi.13384.
36. Ding SW, Voinnet O. 2007. Antiviral immunity directed by small RNAs. Cell
130:413–426. https://doi.org/10.1016/j.cell.2007.07.039.
37. Roth BM, Pruss GJ, Vance VB. 2004. Plant viral suppressors of RNA silenc-
ing. Virus Res 102:97–108. https://doi.org/10.1016/j.virusres.2004.01.020.
38. Muhammad T, Zhang F, Zhang Y, Liang Y. 2019. RNA interference: a natu-
ral immune system of plants to counteract biotic stressors. Cells 8:38.
https://doi.org/10.3390/cells8010038.
39. Li FF, Wang AM. 2018. RNA decay is an antiviral defense in plants that is
counteracted by viral RNA silencing suppressors. PLoS Pathog 14:
e1007228. https://doi.org/10.1371/journal.ppat.1007228.
40. Hu F, Lei R, Deng YF, Wang J, Li GF, Wang CN, Li ZH, Zhu SF. 2018. Discov-
ery of novel inhibitors of RNA silencing suppressor P19 based on virtual
screening. RSC Adv 8:10532–10540. https://doi.org/10.1039/C8RA01311J.
41. Shimura H, Fukagawa T, Meguro A, Yamada H, Oh-Hira M, Sano S, Masuta
C. 2008. A strategy for screening an inhibitor of viral silencing suppres-
sors, which attenuates symptom development of plant viruses. FEBS Lett
582:4047–4052. https://doi.org/10.1016/j.febslet.2008.10.046.
42. Sagan SM, Koukiekolo R, Rodgers E, Goto NK, Pezacki JP. 2007. Inhibition
of siRNA binding to a p19 viral suppressor of RNA silencing by cysteine al-
kylation. Angew Chem Int Ed Engl 46:2005–2009. https://doi.org/10.1002/
anie.200603284.
43. Mat Jalaluddin NS, Othman RY, Harikrishna JA. 2019. Global trends in
research and commercialization of exogenous and endogenous RNAi
technologies for crops. Crit Rev Biotechnol 39:67–78. https://doi.org/10
.1080/07388551.2018.1496064.
44. Dalakouras A, Wassenegger M, Dadami E, Ganopoulos I, Pappas ML,
Papadopoulou K. 2020. Genetically modified organism-free RNA interfer-
ence: exogenous application of RNA molecules in plants. Plant Physiol
182:38–50. https://doi.org/10.1104/pp.19.00570.
45. Worrall EA, Bravo-Cazar A, Nilon AT, Fletcher SJ, Robinson KE, Carr JP,
Mitter N. 2019. Exogenous application of RNAi-inducing double-stranded
RNA inhibits aphid-mediated transmission of a plant virus. Front Plant Sci
10:265. https://doi.org/10.3389/fpls.2019.00265.
46. Mitter N, Worrall EA, Robinson KE, Xu ZP, Carroll BJ. 2017. Induction of vi-
rus resistance by exogenous application of double-stranded RNA. Curr
Opin Virol 26:49–55. https://doi.org/10.1016/j.coviro.2017.07.009.
47. Tenllado F, Martinez-Garcia B, Vargas M, Diaz-Ruiz JR. 2003. Crude extracts
of bacterially expressed dsRNA can be used to protect plants against virus
infections. BMC Biotechnol 3:3. https://doi.org/10.1186/1472-6750-3-3.
48. Konakalla NC, Kaldis A, Berbati M, Masarapu H, Voloudakis AE. 2016. Exog-
enous application of double-stranded RNA molecules from TMV p126
and CP genes confers resistance against TMV in tobacco. Planta
244:961–969. https://doi.org/10.1007/s00425-016-2567-6.
49. Thakur CS, Jha BK, Dong B, Das Gupta J, Silverman KM, Mao H, Sawai H,
Nakamura AO, Banerjee AK, Gudkov A, Silverman RH. 2007. Small-molecule
activators of RNase L with broad-spectrum antiviral activity. Proc Natl Acad
Sci U S A 104:9585–9590. https://doi.org/10.1073/pnas.0700590104.
50. Klumpp K, Hang JQ, Rajendran S, Yang Y, Derosier A, In PWK, Overton H,
Parkes KEB, Cammack N, Martin JA. 2003. Two-metal ion mechanism of
RNA cleavage by HIV RNase H and mechanism-based design of selective
HIV RNase H inhibitors. Nucleic Acids Res 31:6852–6859. https://doi.org/
10.1093/nar/gkg881.
51. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky
MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS. 2004.
Glide: a new approach for rapid, accurate docking and scoring. 1. Method
and assessment of docking accuracy. J Med Chem 47:1739–1749. https://
doi.org/10.1021/jm0306430.
52. Miyashita S. 2018. Studies on replication and evolution mechanisms of
plant RNA viruses. J Gen Plant Pathol 84:427–428. https://doi.org/10
.1007/s10327-018-0806-3.
53. Cai X, Zheng W, Li Z. 2019. High-throughput screening strategies for
the development of anti-virulence inhibitors against Staphylococcus
aureus. Curr Med Chem 26:2297–2312. https://doi.org/10.2174/
0929867324666171121102829.
54. Klostermeier D, Sears P, Wong CH, Millar DP, Williamson JR. 2004. A three-
fluorophore FRET assay for high-throughput screening of small-molecule
inhibitors of ribosome assembly. Nucleic Acids Res 32:2707–2715. https://
doi.org/10.1093/nar/gkh588.
55. Entzian C, Schubert T. 2016. Studying small molecule-aptamer interac-
tions using microscale thermophoresis (MST). Methods 97:27–34. https://
doi.org/10.1016/j.ymeth.2015.08.023.
56. Patching SG. 2014. Surface plasmon resonance spectroscopy for charac-
terisation of membrane protein-ligand interactions and its potential for
drug discovery. Biochim Biophys Acta 1838:43–55. https://doi.org/10
.1016/j.bbamem.2013.04.028.
57. Retra K, Irth H, van Muijlwijk-Koezen JE. 2010. Surface plasmon resonance
biosensor analysis as a useful tool in FBDD. Drug Discov Today Technol 7:
e181–e187. https://doi.org/10.1016/j.ddtec.2010.11.012.
58. Selberg S, Blokhina D, Aatonen M, Koivisto P, Siltanen A, Mervaala E,
Kankuri E, Karelson M. 2019. Discovery of small molecules that activate
RNA methylation through cooperative binding to the METTL3-14-WTAP
complex active site. Cell Rep 26:3762–3771.e5. https://doi.org/10.1016/j
.celrep.2019.02.100.
59. Suree N, Yi SW, Thieu W, Marohn M, Damoiseaux R, Chan A, Jung ME,
Clubb RT. 2009. Discovery and structure-activity relationship analysis of
Staphylococcus aureus sortase A inhibitors. Bioorg Med Chem
17:7174–7185. https://doi.org/10.1016/j.bmc.2009.08.067.
60. Katoh K, Misawa K, Kuma K, Miyata T. 2002. MAFFT: a novel method for
rapid multiple sequence alignment based on fast Fourier transform.
Nucleic Acids Res 30:3059–3066. https://doi.org/10.1093/nar/gkf436.
61. Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. 2015. The I-TASSER suite:
protein structure and function prediction. Nat Methods 12:7–8. https://
doi.org/10.1038/nmeth.3213.
62. Wang QC, Valkonen JP. 2008. Elimination of two viruses which interact syn-
ergistically from sweetpotato by shoot tip culture and cryotherapy. J Virol
Methods 154:135–145. https://doi.org/10.1016/j.jviromet.2008.08.006.
63. Rao X, Huang X, Zhou Z, Lin X. 2013. An improvement of the 2(2delta
delta CT) method for quantitative real-time polymerase chain reaction
data analysis. Biostat Bioinforma Biomath 3:71–85.
Inhibitor Identification for a Viral RNase III Journal of Virology
June 2021 Volume 95 Issue 12 e00107-21 jvi.asm.org 15
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
19
 J
un
e 
20
21
 b
y 
12
8.
21
4.
21
5.
13
3.
